Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).

A Leary; A Evans; SR Johnston; R A'Hern; JM Bliss; R Sahoo; S Detre; BP Haynes; M Hills; C Harper-Wynne; G Coombes; N Bundred; I Smith; M. Dowsett

doi:10.1158/1078-0432.CCR-14-1428

Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).

A Leary, A Evans, SR Johnston, R A'Hern, JM Bliss, R Sahoo, S Detre, BP Haynes, M Hills, C Harper-Wynne, G Coombes, N Bundred, I Smith, M. Dowsett

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2932-2940
Number of pages	8
Journal	Clinical Cancer Research
Volume	21
Issue number	13
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-1428
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-14-1428

Cite this

Leary, A., Evans, A., Johnston, SR., A'Hern, R., Bliss, JM., Sahoo, R., Detre, S., Haynes, BP., Hills, M., Harper-Wynne, C., Coombes, G., Bundred, N., Smith, I., & Dowsett, M. (2015). Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039). Clinical Cancer Research, 21(13), 2932-2940. https://doi.org/10.1158/1078-0432.CCR-14-1428

@article{31ba881a94e54ed5bf5627a81e37d4fb,

title = "Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).",

author = "A Leary and A Evans and SR Johnston and R A'Hern and JM Bliss and R Sahoo and S Detre and BP Haynes and M Hills and C Harper-Wynne and G Coombes and N Bundred and I Smith and M. Dowsett",

year = "2015",

doi = "10.1158/1078-0432.CCR-14-1428",

language = "English",

volume = "21",

pages = "2932--2940",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "13",

}

Leary, A, Evans, A, Johnston, SR, A'Hern, R, Bliss, JM, Sahoo, R, Detre, S, Haynes, BP, Hills, M, Harper-Wynne, C, Coombes, G, Bundred, N, Smith, I & Dowsett, M 2015, 'Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).', Clinical Cancer Research, vol. 21, no. 13, pp. 2932-2940. https://doi.org/10.1158/1078-0432.CCR-14-1428

TY - JOUR

T1 - Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).

AU - Leary, A

AU - Evans, A

AU - Johnston, SR

AU - A'Hern, R

AU - Bliss, JM

AU - Sahoo, R

AU - Detre, S

AU - Haynes, BP

AU - Hills, M

AU - Harper-Wynne, C

AU - Coombes, G

AU - Bundred, N

AU - Smith, I

AU - Dowsett, M.

PY - 2015

Y1 - 2015

U2 - 10.1158/1078-0432.CCR-14-1428

DO - 10.1158/1078-0432.CCR-14-1428

M3 - Article

SN - 1078-0432

VL - 21

SP - 2932

EP - 2940

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 13

ER -